Distinguished in Hereditary Spastic Paraparesis

Ivana Ricca

Via Dei Giacinti 2, 
Pisa, IT 
Distinguished in Hereditary Spastic Paraparesis
Via Dei Giacinti 2, 
Pisa, IT 
OverviewLocationsClinical Research

Overview

Ivana Ricca practices in Pisa, Italy. Ms. Ricca is rated as a Distinguished expert by MediFind in the treatment of Hereditary Spastic Paraparesis. Her top areas of expertise are Spastic Paraplegia Type 2, Spastic Paraplegia Type 7, Hereditary Spastic Paraparesis, and Spastic Ataxia Charlevoix-Saguenay Type.

Her clinical research consists of co-authoring 37 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles and participated in 2 clinical trials in the study of Hereditary Spastic Paraparesis.

Gender
Female

Locations

Via Dei Giacinti 2, Pisa, 56128, Italy
Other Locations
Calambrone, Italy
Rome, Italy
Pavia, Italy
Milan, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

An Observational Study in Subjects With Spastic Paraplegia Type 11 Taking Trehalose
An Observational Study in Subjects With Spastic Paraplegia Type 11 Taking Trehalose
Enrollment Status: Completed
Publish Date: August 03, 2022
A Study in Subjects With Neuronal Ceroid Lipofuscinoses Taking Trehalose
A Study in Subjects With Neuronal Ceroid Lipofuscinoses Taking Trehalose
Enrollment Status: Completed
Publish Date: April 11, 2022
Phase 2 Pharmacological Trial to Evaluate the Safety of Miglustat Administration in Subjects With Spastic Paraplegia 11 (TreatSPG11)
Phase 2 Pharmacological Trial to Evaluate the Safety of Miglustat Administration in Subjects With Spastic Paraplegia 11 (TreatSPG11)
Enrollment Status: Completed
Publish Date: April 11, 2022
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

37 Total Publications

Correction: Open-label evaluation of oral trehalose in patients with neuronal ceroid lipofuscinoses.
Correction: Open-label evaluation of oral trehalose in patients with neuronal ceroid lipofuscinoses.
Journal: Journal of neurology
Published: October 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Ricca's expertise for a condition
ConditionClose
    View All 16 Advanced Conditions
    View All 22 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile